Continued improvement in cardiac T2*with deferasirox treatment over 2 years: Results from the extension of epic cardiac substudy in beta-thalassaemia patients with myocardial siderosis

相似书籍

• Deferasirox effectively removes cardiac iron in beta-thalassaemia patients with myocardial siderosis previously chelated with deferoxamine monotherapy or deferoxamine-deferiprone therapy
  由: Pennell, D., et al.
  出版: (2010)
• Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia
  由: Pennell, D.J., et al.
  出版: (2010)
• Efficacy of deferasirox in patients with thalassaemia major is not affected by a history of hepatitis B OR C
  由: Cappellini, M.D., et al.
  出版: (2010)
• Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years
  由: Pennell, D., et al.
  出版: (2010)
• Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias
  由: Cappellini, M.D., et al.
  出版: (2010)